Profiles of IFN-γ and its regulatory cytokines (IL-12, IL-18 and IL-10) in peripheral blood mononuclear cells from patients with multidrug-resistant tuberculosis

Clinical and Experimental Immunology

Volumn 128, Issue 3, 2002, Pages 516-524

  Lee, J S ^a   Song, C H ^a   Kim, C H ^b   Kong, S J ^b   Shon, M H ^b   Kim, H J ^a   Park, J K ^a   Paik, T H ^c   Jo, E K ^a  

^a Chungnam National University   (South Korea)

^b National Mokpo Tuberculosis Hospital   (South Korea)

^c Konyang University   (South Korea)

Author keywords

Interferon gamma; Interleukin 10; Interleukin 12; Interleukin 18; Multidrug resistant pulmonary tuberculosis; PPD antigen

Indexed keywords

ANTIGEN; CD4 ANTIGEN; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 12; INTERLEUKIN 18; PROTEIN P70; TUBERCULIN; UNCLASSIFIED DRUG;

ADULT; AGED; ARTICLE; BACTERIAL INFECTION; BLOOD CELL; CLINICAL ARTICLE; CONTROLLED STUDY; CORRELATION ANALYSIS; CYTOKINE PRODUCTION; DISEASE DURATION; DRUG SENSITIVITY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HEALTH STATUS; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS; IN VITRO STUDY; LYMPHOCYTE PROLIFERATION; MALE; MEDICAL LITERATURE; MONONUCLEAR CELL; MULTIDRUG RESISTANCE; MYCOBACTERIUM TUBERCULOSIS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; TUBERCULOSIS;

ADULT; AGED; CD4 LYMPHOCYTE COUNT; CD4-POSITIVE T-LYMPHOCYTES; CELL DIVISION; CELLS, CULTURED; FEMALE; HUMANS; INTERFERON TYPE II; INTERLEUKIN-10; INTERLEUKIN-12; INTERLEUKIN-18; LEUKOCYTES, MONONUCLEAR; MALE; MIDDLE AGED; NEUTRALIZATION TESTS; TUBERCULIN; TUBERCULOSIS, MULTIDRUG-RESISTANT;

EID: 0036277890     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.2002.01858.x     Document Type: Article

References (42)

1. Treatment of 171 patients with pulmonary tuberculosis resistant to isoniazid and rifampin
2. Global epidemiology of tuberculosis. Morbidity and mortality of a worldwide epidemic
3. Immunotherapy for MDR-TB (multi-drug resistant tuberculosis) - Its feasibility
4. T-cell responses and cytokines
5. Cytokine secretion by CD4 T lymphocytes acquired in response to Mycobacterium tuberculosis infection
6. Disseminated tuberculosis in interferon gamma gene-disrupted mice
7. An essential role for interferon gamma in resistance to Mycobacterium tuberculosis infection
8. Predictors of survival in HIV-infected tuberculosis patients
9. Patients with multidrug-resistant tuberculosis with low CD4+ T cell counts have impaired Th1 responses
10. IL-12 and the human response to mycobacteria
11. Overview of interleukin-18: More than an interferon-gamma inducing factor
12. Immunoregulation by interleukin-12
13. Cloning of cDNA for natural killer cell stimulatory factor, a heterodimeric cytokine with multiple biologic effects on T and natural killer cells
14. The role of interleukin-12 in acquired immunity to Mycobacterium tuberculosis infection
15. IL-12 increases resistance of BALB/c mice to Mycobacterium tuberculosis infection
16. Endotoxin-induced serum factor that stimulates gamma interferon production
17. Quantification of human interleukin 18 mRNA expression by competitive reverse transcriptase polymerase chain reaction
18. IFN-gamma-inducing factor (IGIF) is a costimulatory factor on the activation of Th1 but not Th2 cells and exerts its effect independently of IL-12
19. Cloning of a new cytokine that induces IFN-gamma production by T cells
20. IL-12 up-regulates IL-18 receptor expression on T cells, Th1 cells, and B cells: Synergism with IL-18 for IFN-gamma production
21. Review: The immune response in human tuberculosis-implications for tuberculosis control
22. Interleukin-10
23. Transforming growth factor beta (TGF-beta) in inflammation. A cause and a cure
24. Depressed IL-12, but not IL-18 production in response to a 30-and 32-kDa mycobacterial antigen in patients with active pulmonary tuberculosis
25. Dysregulated production of interferon-gamma, interleukin-4 and interleukin-6 in early tuberculosis patients in response to antigen 85B of Mycobacterium tuberculosis
26. Cytokine profiles for peripheral blood lymphocytes from patients with active pulmonary tuberculosis and healthy household contacts in response to the 30-kilodalton antigen of Mycobacterium tuberculosis
27. In vitro synthesis of interferon-gamma, interleukin-4, transforming growth factor-beta and interleukin-1 beta by peripheral blood mononuclear cells from tuberculosis patients: Relationship with the severity of pulmonary involvement
28. Influence of disease severity on nitrite and cytokine production by peripheral blood mononuclear cells (PBMC) from patients with pulmonary tuberculosis (TB)
29. Apoptosis and T cell hyporesponsiveness in pulmonary tuberculosis
30. Interleukin-12. A cytokine produced by antigen-presenting cells with immunoregulatory functions in the generation of T-helper cells type 1 and cytotoxic lymphocytes
31. Expression of the IL-12 receptor beta 1 and beta 2 subunits in human tuberculosis
32. A role for IL-12 receptor expression and signal transduction in host defense in leprosy
33. Interaction of Mycobacterium tuberculosis-induced transforming growth factor beta 1 and interleukin-10
34. Modulation of IL-12 by transforming growth factor-beta (TGF-beta) in Mycobacterium tuberculosis-infected mononuclear phagocytes and in patients with active tuberculosis
35. Cloning of the cDNA for human IFN-gamma-inducing factor, expression inEscherichia coli, and studies on the biologic activities of the protein
36. IL-18 protects mice against pulmonary and disseminated infection with Cryptococcus neoformans by inducing IFN-gamma production
37. Altered immune responses and susceptibility to Leishmania major and Staphylococcus aureus infection in IL-18-deficient mice
38. Interleukin 18 contributes to host resistance and gamma interferon production in mice infected with virulent Salmonella typhimurium
39. Role of interleukin-18 (IL-18) in mycobacterial infection in IL-18-gene-disrupted mice
40. Production of interleukin-18 in human tuberculosis
41. IL-18 promotes type 1 cytokine production from NK cells and T cells in human intracellular infection
42. Increased levels of circulating interleukin-18 in patients with advanced tuberculosis